Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Discover Hybrigenics Services new offer: ULTImate YChemH for your drug discovery & development projects

Product Image
Product Description

ULTImate YChemH (Yeast Chemical Hybrid) is an in-yeast compound profiling technique to identify protein partners of a given bioactive small molecule. Derived from Hybrigenics ULTImate Y2HTM (Yeast Two-Hybrid) service, it benefits from the same advantages with exhaustive screening of highly complex libraries, confidence score for partners ranking, minimal interaction domain determination and much more…

Applications

  • Identify hit targets and decipher mechanisms of action following a high-content screening
  • Study the off-target effect of an active compound
  • Support drug repositioning in new therapeutic areas
  • Evaluate safety of chemicals (toxico-proteomics) 

Process

Process_YChemHimage.gif

Key Benefits

  • Gain in productivity with additional resources
  • Benefit from our expertise in both chemistry and biology
  • Understand how your bioactive molecule works
  • Select the most promising molecule & develop it the optimal way

Contact our team of experts for any question or for a project discussion: 

+33 (0)1 58 10 38 29
services@hybrigenics.com

Product Discover Hybrigenics Services new offer: ULTImate YChemH for your drug discovery & development projects
Company Hybrigenics Services
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Hybrigenics Services
3-5 Impasse Reille 75014 Paris France

Tel: +33 (0)1 58 10 38 29
Fax: +33 (0)1 58 10 38 48
Email: services@hybrigenics.com



Scientific News
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Faster UVA Molecular Analysis Technology
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level.
Scientists Synthesize Anti-Cancer Agent
A team led by Rice University synthetic organic chemist K.C. Nicolaou has developed a new process for the synthesis of a series of potent anti-cancer agents originally found in bacteria.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!